Tetra Bio-Pharma (TSX: TBP) (OTC-Pink: TBPMF) (FRA: JAM1) is a biopharmaceutical leader in cannabinoid-based drug discovery and development with a clinical program aimed at bringing novel drugs and treatments to patients and their healthcare providers. Some statements in this page may contain forward-looking information. Please refer to Tetra Bio-Pharma's annual regulatory filing for the risks and uncertainties.
